Home - Products - Endocrinology/Hormones - AChR - Galanthamine N-Oxide

Galanthamine N-Oxide

CAS No. 134332-50-6

Galanthamine N-Oxide( —— )

Catalog No. M23501 CAS No. 134332-50-6

Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	249	In Stock
5MG	217	In Stock
10MG	353	In Stock
25MG	582	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Galanthamine N-Oxide
Note

Research use only, not for human use.
Brief Description

Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM.
Description

Galanthamine N-Oxide inhibits electric eel acetylcholinesterase (AChE) with an EC50 of 26.2 μM. Galanthamine N-Oxide is a prominent inhibitor of substrate accommodation in the active site of the Torpedo californica AChE (TcAChE), hAChE and hBChE enzymes. Galanthamine N-Oxide is an alkaloid obtained from the bulbs of Zephyranthes concolor.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

AChR
Recptor

AChE
Research Area

——
Indication

——

Chemical Information

CAS Number

134332-50-6
Formula Weight

303.35
Molecular Formula

C17H21NO4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 6.25 mg/mL (20.60 mM)
SMILES

O[C@H]1C=C[C@@]23CC[N@@+](C)([O-])CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Reyes-Chilpa R, et al. Acetylcholinesterase-inhibiting alkaloids from Zephyranthes concolor. Molecules. 2011 Nov 15;16(11):9520-33.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

VASICINE

Vasicine is oxytocic and abortifacient agents.Vasicine a potential natural cholinesterase inhibitor has been in development for treatment of Alzheimer's disease.
PHA 568487

The quinuclidine PHA 568487 is an agonist of the alpha 7 nicotinic acetylcholine receptor that was designed to mitigate the bioactivation associated with the core scaffold and subsequently remove associated liabilities with in vivo tolerability.
Scopolamine N-oxide ...

A muscarinic antagonist used to study binding characteristics of muscarinic cholinergic receptors.

Sign In Join Free